Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs

Birth Defects Res A Clin Mol Teratol. 2008 Jul;82(7):540-2. doi: 10.1002/bdra.20454.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5,10-Methylenetetrahydrofolate Reductase (FADH2) / genetics
  • Adult
  • Cystathionine beta-Synthase / genetics
  • Drug Resistance*
  • Female
  • Ferredoxin-NADP Reductase / genetics
  • Folic Acid / administration & dosage
  • Folic Acid / pharmacology*
  • Folic Acid / therapeutic use
  • Humans
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Infant, Premature
  • Inositol* / administration & dosage
  • Inositol* / therapeutic use
  • Male
  • Neural Tube Defects / etiology
  • Neural Tube Defects / prevention & control*
  • Polymorphism, Genetic
  • Pregnancy
  • Pregnancy Outcome*
  • Risk Factors

Substances

  • Inositol
  • Folic Acid
  • methionine synthase reductase
  • Ferredoxin-NADP Reductase
  • 5,10-Methylenetetrahydrofolate Reductase (FADH2)
  • Cystathionine beta-Synthase